Panel Member	Clinical Research Support	Advisory Boards, Speakers Bureau, Expert Witness, or Consultant	Patent, Equity, or Royalty	Other	Date Completed
Ellin Berman, MD	Novartis Pharmaceuticals Corporation	None	None	None	11/18/2009
Hossein Borghaei, DO, MS	Genentech, Inc.; Spectrum	Amgen Inc.; Eli Lilly and Company; Genentech, Inc.	None	None	10/2/2009
Daniel J. DeAngelo, MD, PhD	None	Bristol-Myers Squibb Company; Celgene Corporation; Enzon Pharmaceuticals; Novartis Pharmaceuticals Corporation; Pharmion Corporation	None	None	11/17/2009
Marcel P. Devetten, MD	None	Bristol-Myers Squibb Company; Novartis Pharmaceuticals Corporation	None	None	11/17/2009
Steven Devine, MD	Genzyme Corporation	Novartis Pharmaceuticals Corporation; Takeda Pharmaceuticals North America, Inc.	None	None	9/29/2009
Harry P. Erba, MD, PhD	Cephalon, Inc.; Eli Lilly and Company; Exelixis Inc.; Genzyme Corporation; Kanisa Pharmaceuticals, Inc.; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Wyeth Pharmaceuticals; Xanthus Pharmacueuticals, Inc.	Bristol-Myers Squibb Company; Celgene Corporation; Cephalon, Inc.; Genzyme Corporation; MGI PHARMA, INC.; Novartis Pharmaceuticals Corporation; Pharmion Corporation	None	National Cancer Institute	11/17/2009
Lauren Gallagher, PhD	None	None	None	None	8/28/2009
Jason Gotlib, MD, MS	None	Novartis Pharmaceuticals Corporation	None	None	9/30/2009
Kristina M Gregory, RN, MSN, OCN	None	None	None	None	8/21/2009
Madan Jagasia, MD	None	None	None	None	10/18/2009
Joan S McClure, MS	None	None	None	None	9/28/2009
Joseph O. Moore, MD	Genentech, Inc.; Novartis Pharmaceuticals Corporation	Amgen Inc.; Genentech, Inc.; Novartis Pharmaceuticals Corporation	None	None	10/28/2009
Tariq I. Mughal, MD, FRCP	Celgene Corporation; Novartis Pharmaceuticals Corporation	Bristol-Myers Squibb Company; Celgene Corporation; Novartis Pharmaceuticals Corporation	None	None	10/7/2009
Susan O'Brien, MD	None	None	None	None	7/1/2009
Javier Pinilla-Ibarz, MD, PhD	Bristol-Myers Squibb Company; Exelixis Inc.; Novartis Pharmaceuticals Corporation; Innovive	Novartis Pharmaceuticals Corporation; Innovive	None	None	11/17/2009
Jerald P. Radich, MD	Bristol-Myers Squibb Company; Novartis Pharmaceuticals Corporation	Bristol-Myers Squibb Company; Novartis Pharmaceuticals Corporation	None	None	11/18/2009
Neil P. Shah, MD, PhD					Pending
Paul J. Shami, MD	Genzyme Corporation	Novartis Pharmaceuticals Corporation	JSK Therapeutics Inc.	None	10/28/2009
B. Douglas Smith, MD	Bayer HealthCare; Cephalon, Inc.; Novartis Pharmaceuticals Corporation	Bristol-Myers Squibb Company; Novartis Pharmaceuticals Corporation	None	None	10/28/2009
David S. Snyder, MD	Bristol-Myers Squibb Company; Novartis Pharmaceuticals Corporation	Bristol-Myers Squibb Company; Novartis Pharmaceuticals Corporation	None	None	7/1/2009
Hema Sundar, PhD	None	None	None	Cephalon, Inc.	12/15/2008
Martin S. Tallman, MD	None	Genzyme Corporation	None	None	10/28/2009
Moshe Talpaz, MD	None	ARIAD Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation	None	None	10/6/2009
Meir Wetzler, MD	Cephalon, Inc.; Genzyme Corporation	Bristol-Myers Squibb Company; Enzon Pharmaceuticals; Novartis Pharmaceuticals Corporation	None	None	11/17/2009

NCCN Website Supporters